CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2022		75,670,000
Beginning balance at Dec. 31, 2022	$ 165,420	$ 76	$ 279,552	$ (115,893)	$ 1,685
Increase (Decrease) in Stockholders' Equity
Exercise of options (in shares)		166,000
Exercise of options	209	$ 0	209
Stock based compensation expense	365		365
Non controlling shareholder contribution	980				980
Net income (loss)	53,813			53,863	(50)
Ending balance (in shares) at Mar. 31, 2023		75,836,000
Ending balance at Mar. 31, 2023	220,787	$ 76	280,126	(62,030)	2,615
Beginning balance (in shares) at Dec. 31, 2023		93,515,000
Beginning balance at Dec. 31, 2023	200,387	$ 94	383,632	(187,379)	4,040
Increase (Decrease) in Stockholders' Equity
Exercise of options (in shares)		166,000
Stock based compensation expense	431		431
Net income (loss)	(17,854)			(17,734)	(120)
Ending balance (in shares) at Mar. 31, 2024		93,515,000
Ending balance at Mar. 31, 2024	$ 182,964	$ 94	$ 384,063	$ (205,113)	$ 3,920